Skip to main content
Premium Trial:

Request an Annual Quote

SpeeDx Signs UK, Ireland Distribution Deal

NEW YORK (GenomeWeb) – Australian diagnostics firm SpeeDx announced today that it has signed a distribution deal for its molecular diagnostics in the UK and Ireland with Serosep.

Under the terms of the deal, Serosep will offer SpeeDx's line of multiplexed PlexPCR and ResistancePlus tests throughout the territories. Additional terms were not disclosed.

Last year, SpeeDx — which recently opened a US subsidiary — received CE-IVD marking for its PlexPCR VHS test for VZV, herpes, and syphilis. It also offers the ResistancePlus MG assay for Mycoplasma genitalium. In September, SpeeDx signed a distribution deal for its products covering Scandinavia with Diagen.

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.